Nanosonics Limited

$ 3.31 2.80 %

Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinfection system, including all related supplies and accessories. Additionally, it dedicates resources to the exploration, development, and market launch of innovative infection control, decontamination products, and their associated technologies. Key offerings from Nanosonics include trophon2, an advanced device for high-level disinfection of ultrasound probes; trophon EPR, a low-temperature, high-level disinfection method specifically for intra-cavity ultrasound probes; and Nanosonics AuditPro, a comprehensive solution for managing compliance with infection control workflows. Established in 2000, Nanosonics Limited is headquartered in Macquarie Park, Australia.

CEO: Michael C. Kavanagh - https://www.nanosonics.com.au

Price objectif

-

Recommandation

-

DCF

$ 2.25

Loading data...

NAN.AX vs S&P500

Loading data...

No data available.

Quick ratio

5.75

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

47.29

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.07

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

9.57 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

7.04 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

10.01

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.04

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.08

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

0.00 %

the dividend payout ratio is the measure of dividends paid out to shareholders relative to the company's net income.

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
12.99 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
4.37 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.04 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.